Ingredient
Distearyl Phthalic Acid Amide
Distearyl Phthalic Acid Amide is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is hormone disruptor and fetal development.
- Distearyl Phthalamide
- DSPA
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Distearyl Phthalic Acid Amide and pregnancy
Caution Advised
- Hormone disruptor
- Fetal development
Distearyl phthalic acid amide is an emollient derived from phthalic acid, which is chemically related to phthalates. While it's not a traditional phthalate plasticizer, its structural similarity raises questions about potential endocrine-disrupting effects. According to ACOG, certain phthalates have been associated with reproductive and developmental concerns, including altered hormone levels and potential effects on fetal development. While this specific derivative lacks comprehensive pregnancy safety data, its chemical relationship to restricted phthalates suggests a precautionary approach is warranted. Studies on phthalate exposure during pregnancy have shown associations with preterm birth and developmental effects, though these studies primarily examined plasticizer phthalates rather than cosmetic derivatives. Many obstetricians and dermatologists recommend pregnant women minimize exposure to phthalate-related compounds when possible, given the documented concerns with traditional phthalates. While this ingredient is not explicitly prohibited, the lack of robust safety data combined with its chemical structure suggests choosing well-studied alternatives may be prudent.
Distearyl Phthalic Acid Amide and breastfeeding
Caution Advised
- Passes into breast milk
- Infant exposure
Distearyl phthalic acid amide is a fat-soluble emollient with potential for skin absorption. Given its lipophilic nature and chemical similarity to phthalates, there are theoretical concerns about transfer into breast milk. Studies have detected various phthalate metabolites in breast milk, raising concerns about infant exposure through breastfeeding. While this specific phthalic acid derivative has not been studied in breast milk, its chemical properties suggest similar behavior may be possible. The AAD notes that minimizing exposure to potentially endocrine-disrupting compounds is generally advised during breastfeeding. Many lactation consultants and dermatologists suggest avoiding phthalate-related ingredients during breastfeeding due to theoretical infant exposure risks. Given the availability of well-studied emollient alternatives, many breastfeeding mothers choose to use products with more established safety profiles.
Distearyl Phthalic Acid Amide and postpartum
Safe to Use
For postpartum women who are not breastfeeding, distearyl phthalic acid amide presents fewer concerns since there's no risk of infant exposure through breast milk. Its emollient properties can support skin barrier function during postpartum recovery. Without pregnancy or breastfeeding considerations, the primary concern would be individual skin tolerance and the general uncertainty around phthalate-related compounds. Women with sensitive skin may prefer more established alternatives.
Distearyl Phthalic Acid Amide and trying to conceive
Caution Advised
- Fertility effects
- Hormone disruptor
Distearyl phthalic acid amide's structural relationship to phthalates raises questions about potential effects on fertility and reproductive health. While specific studies on this derivative and fertility are lacking, the broader literature on phthalates and reproduction suggests a cautious approach. Research has associated certain phthalate exposures with altered hormone levels and potential fertility effects in both men and women. Women trying to conceive may wish to minimize exposure to phthalate-related compounds during this critical preconception period. Most fertility specialists recommend reducing exposure to potential endocrine disruptors when attempting to conceive.
Distearyl Phthalic Acid Amide and PCOS
Caution Advised
- Interferes with hormones
- Endocrine disruptor
Distearyl phthalic acid amide is structurally related to phthalates, which have been studied for potential endocrine-disrupting properties. For women with PCOS, who already experience hormonal imbalances, exposure to potential hormone disruptors is a particular concern. Research has shown that certain phthalates can interfere with reproductive hormones and may affect androgen levels. While this specific derivative lacks direct studies in PCOS populations, its chemical similarity to compounds known to affect hormone signaling suggests caution is warranted. Some studies have linked phthalate exposure to insulin resistance and metabolic dysfunction, conditions often comorbid with PCOS. Many endocrinologists recommend women with PCOS minimize exposure to potential endocrine disruptors as part of comprehensive PCOS management. Given the availability of emollients without phthalate-related structures, choosing alternatives may be preferable for this population.
Distearyl Phthalic Acid Amide and general use
Safe to Use
Distearyl phthalic acid amide functions as an emollient in cosmetic formulations, providing skin-softening properties and improving product texture. It's used in various skincare products for its conditioning effects. For the general population without specific health concerns, this ingredient appears to have a relatively low risk profile when used topically. The main considerations are its comedogenic potential and the ongoing scientific discussion about phthalate-related compounds in personal care products. While it's not prohibited in cosmetics, the evolving understanding of phthalate-related compounds means some consumers choose alternatives out of general precaution. The ingredient is generally well-tolerated when used in standard cosmetic formulations.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Distearyl Phthalic Acid Amide, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store